Actively Recruiting
Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR
Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2025-12-22
1500
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aimed to compare the clinical and angiographic outcomes of patients with DES-ISR who underwent repeat PCI with intravascular imaging or angiographic guidance.
CONDITIONS
Official Title
Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with drug-eluting stent in-stent restenosis (DES-ISR) lesions
- Life expectancy of at least 1 year
- DES-ISR lesions occurring for the first time in native coronary arteries and suitable for repeat PCI based on angiographic findings
You will not qualify if you...
- Bare-metal stent in-stent restenosis (BMS-ISR)
- Non-DES-ISR lesions
- Incomplete clinical and angiographic data
- Poor quality of intravascular ultrasound (IVUS) or angiographic images
- Recurrent DES-ISR
- Previous optical coherence tomography (OCT) guidance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nanjing First Hospital
Nanjing, Jiangsu, China, 210006
Actively Recruiting
Research Team
F
Fei Ye, MD
CONTACT
Y
Yi-fei Wang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here